Status:
COMPLETED
Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin
Lead Sponsor:
Corporacion Parc Tauli
Conditions:
Type 2 Diabetes Treated With Insulin
Obesity
Eligibility:
All Genders
12-19 years
Phase:
NA
Brief Summary
To compare the efficacy and effect on glycemic control of Dulaglutide versus Liraglutide in obese Type 2 diabetic adolescents using metformin
Detailed Description
To observe the efficacy, effect on glycemic control, impact on BMI and incidence of adverse effects of Dulaglutide and to compare it to Liraglutide in individuals aged thirteen to eighteen who have Ty...
Eligibility Criteria
Inclusion
- Type 2 Diabetes Mellitus
- Obese
- Taking metformin
- Male or female
Exclusion
- Non obese
- Not taking metformin
- Taking other injectable diabetic medications
Key Trial Info
Start Date :
January 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 20 2021
Estimated Enrollment :
116 Patients enrolled
Trial Details
Trial ID
NCT04829903
Start Date
January 2 2020
End Date
November 20 2021
Last Update
March 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zainab Khan
Lahore, Punjab Province, Pakistan